Real-time enrollment status for this phenylketonuria clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:48 PM UTC
| NCT Number | NCT06971731 |
| Recruiting Status | Recruiting |
| Condition | Phenylketonuria |
| Phase | PHASE3 |
| Target Enrollment | 120 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | July 8, 2026 (Jul 8, 2026) |
As of August 27, 2026: Clinical trial NCT06971731 is currently recruiting participants. This phase3 study for phenylketonuria is actively seeking new participants at 10 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06971731 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06971731 was last updated Jul 8, 2026 (July 8, 2026). HelloStudys verifies this status automatically.